XBIOTECH INC. Retained Earnings
XBIOTECH INC. (XBIT) had Retained Earnings of -$148.61 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$148.61M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$141.88M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$136.38M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$109.48M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$148.61M 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$141.88M 10-Q · filed 2026-05-14 |
| 2025-12-31 | -$136.38M 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$109.48M 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$103.48M 10-Q · filed 2025-08-13 |
| 2025-03-31 | -$101.72M 10-Q · filed 2025-05-14 |
| 2024-12-31 | -$90.84M 10-K · filed 2026-03-13 |
| 2024-09-30 | -$80.33M 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$75.31M 10-Q · filed 2024-08-12 |
| 2024-03-31 | -$62.31M 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$52.31M 10-K · filed 2025-03-18 |
| 2023-09-30 | -$47.67M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$40.31M 10-Q · filed 2023-08-11 |
| 2023-03-31 | -$31.57M 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$27.75M 10-K · filed 2024-03-15 |
| 2022-09-30 | -$24.55M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$11.89M 10-Q · filed 2022-08-10 |
| 2022-03-31 | -$244.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $5.15M 10-K · filed 2023-03-15 |
| 2021-09-30 | $11.62M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $89.88M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $95.00M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $97.57M 10-K · filed 2022-03-15 |
| 2020-09-30 | $94.79M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $97.31M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $104.16M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $430.93M 10-K · filed 2021-03-16 |
| 2019-09-30 | -$255.57M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$249.42M 10-Q · filed 2019-08-09 |
| 2019-03-31 | -$243.56M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$237.70M 10-K · filed 2020-03-16 |
| 2018-09-30 | -$231.59M 10-Q · filed 2018-10-31 |
| 2018-06-30 | -$226.54M 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$220.63M 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$216.56M 10-K/A · filed 2019-03-15 |
| 2017-09-30 | -$209.31M 10-Q · filed 2017-11-09 |
| 2017-06-30 | -$203.11M 10-Q · filed 2017-08-08 |
| 2017-03-31 | -$193.97M 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$183.41M 10-K · filed 2018-03-16 |
| 2016-09-30 | -$167.01M 10-Q · filed 2016-11-14 |
| 2016-06-30 | -$154.53M 10-Q · filed 2016-08-12 |
| 2016-03-31 | -$140.91M 10-Q · filed 2016-05-13 |
| 2015-12-31 | -$130.65M 10-K · filed 2017-03-16 |
| 2015-09-30 | -$118.76M 10-Q · filed 2015-11-13 |
| 2015-06-30 | -$108.03M 10-Q · filed 2015-08-14 |
| 2015-03-31 | -$101.28M 10-Q · filed 2015-06-18 |
| 2014-12-31 | -$93.17M 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |